| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | 0.02 | 0.5 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.028 | 0.6 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | -0.025 | 0.6 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |